Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Sriveda Sattva Private Limited
Sri Sri Institute of Advanced Research
Eligibility
Inclusion criteria
Inclusion criteria: Age 21 to 75 years b) Symptomatic COVID-19 infected patients with or without comorbidities c) Reported to OPD within three days of onset of symptoms d) Willing to take AYUSH treatment
Exclusion criteria
Exclusion criteria: Not willing to give consent/ participate in the clinical trial b) Age less than 18 years or more than 75 years b) Patients with chronic comorbidities like diabetes, chronic heart conditions and HIV/AIDS c) Pregnant and Lactating mothers d) Patients on immunosuppressive therapy e) SARS-CoV-2 infected patients with oxygen saturation less than 90% or those in ICU
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patients were assessed for improvement from COVID-19 based on their RT-PCR negative results. The primary outcome was the rate of recovery based on viral load reduction, RT-PCR negativity rate.Timepoint: Day 0,3,5,7, 10(if required) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes included clinical improvement among the patients as evaluated by the CBC, CRP. To evaluate the safety of the drug by assessing LFT and KFTTimepoint: Day 0, 5/exit | — |
Countries
India
Contacts
Public ContactDR ABHISHEK ARUN
Atharva Multispecialty Hospital and Research Center
Outcome results
None listed